Novus Acq & Dev Corp (NDEV) 0.0461 $NDEV
Novus Engages Hayden IR to Develop Comprehensive Investor Relations Program
ACCESSWIRE - Wed Aug 03, 7:30AM CDT
Proactive Outreach to Focus on Increasing Awareness and Enhancing Shareholder Value
Novus MedPlan Grows Its MMJ and Alternative Medicine Footprint
ACCESSWIRE - Mon Jun 08, 7:00AM CDT
WHITEFISH, MT / ACCESSWIRE / June 8, 2015 / Novus Acquisition & Development Corp. (OTC: NDEV), developer of a cost-saving healthcare program called "Novus MedPlan" for patients within the medical marijuana (MMJ) and wellness industries, has made substantial progress over the past few months growing its provider network, launching its online platform, and garnering the media attention needed to help it reach scale.
GWPH: 81.63 (+0.09), UAM: 6.84 (-0.11), MGLN: 56.18 (-1.06)
Nations First MMJ Medical Plan Portal Goes Live
ACCESSWIRE - Tue Mar 31, 8:30AM CDT
WHITEFISH, MT / ACCESSWIRE / March 31, 2015 / Novus Acquisition & Development Corp. (PINKSHEETS:NDEV) officially launched its Novus MedPlan in partnership with Proteus420 after months of anticipation from both patients and providers. With the alternative healthcare industry expected to surpass $12 billion in size, according to IBISWorld, the launch represents a key step forward in the complementary and alternative medicine ("CAM"
industry, which includes medical marijuana, alternative medicine, and holistic healing.
GWPH: 81.63 (+0.09)
Novus MedPlan Progress Exceeds Expectations, Company Poised For Banner 2015
ACCESSWIRE - Tue Dec 30, 9:01AM CST
WHITEFISH, MT / ACCESSWIRE / December 30, 2014 / The rapid expansion of the cannabis industry has offered patients throughout the U.S. a ray of hope when it comes to treating a variety of conditions that medical marijuana (MMJ) is increasingly understood to be effective for. However, exorbitant costs for MMJ patients, associated with registration fees and other price pressures put on producers and distributors, have made MMJ treatments inaccessible to a sizeable portion of the market. This is why Novus Acquisition & Development Corp. (OTC: NDEV), created their innovative Novus MedPlan program, which offers MMJ patients a considerable discount on medicinals, as well as holistic and alternative medicines, using an exclusive provider network cost-savings model to grant members direct and easy access to the nearest providers in their state.
JNJ: 119.04 (+0.47), INSY: 15.17 (+0.19), GWPH: 81.63 (+0.09)
Novus Becomes an Insurance Leader as MMJ Market Approaches Tipping Point
ACCESSWIRE - Mon Dec 08, 9:21AM CST
WHITEFISH, MT / ACCESSWIRE / December 8, 2014 / A unique company in the MMJ space today that is focused on the medical insurance side of the business is Novus Acquisition & Development (OTC: NDEV). Novus provides health insurance and insurance related solutions to the growing wellness and MMJ markets using an innovative cost-saving provider network model that is administered via their wholly-owned Novus Medical Group subsidiary's Novus MedPlan. The timely rollout of the Novus MedPlan in states where MMJ is legal, which gives patients access to considerable discounts on MMJ products for a modest subscriber fee of under $20 a month, was recently highlighted in Forbes as the number one pick, taking the top slot out of a list of the eight hottest publicly traded companies to draw the interest of investors in this rapidly emerging sector.
CARA: 5.52 (+0.02), INSY: 15.17 (+0.19), GWPH: 81.63 (+0.09)
Earth Science Tech's Pioneering CBD Work Spearheaded By Leading Cancer Treatment/Diagnostic Expert
ACCESSWIRE - Wed Nov 19, 3:07PM CST
WHITEFISH, MT / ACCESSWIRE / November 19, 2014 / A growing body of data from numerous studies over the past decade has gradually led to a more complete understanding of cannabinoid biology and pharmacology, including efficacy as an appetite stimulant, analgesic (pain reliever) and treatment for neurological disorders like epilepsy. Similar efficacy data regarding cannabinoids performing broad-spectrum anti-tumor functions and producing palliative effects on cancer symptoms, documented by the National Cancer Institute, has made cannabinoid science a hot property in the world of modern oncology medicine. Needless to say, the emerging market surrounding cannabinoids has been booming of late, with a variety of sector players seeing increased interest from investors, ranging from cannabis-based medicine developers like Cannabis Science (OTC: CBIS), to innovative medical cannabis-focused healthcare solution providers, like Novus Acquisition & Development (OTC: NDEV).
GWPH: 81.63 (+0.09)
Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 81.63 (+0.09)
Novus MedPlan Cost-Saving Provider Network Offers A Strong Value Proposition
ACCESSWIRE - Fri Nov 07, 8:01AM CST
WHITEFISH, MT / ACCESSWIRE / November 7, 2014 / Marijuana reform was a key ballot initiative in seven states (as well as 17 municipalities and D.C.) this week, with more drug policy reform questions (most aimed at reforming or out outright repealing marijuana laws) on the ballot than at any time in the history of the country. In California, Proposition 47 was passed, transforming the lowest-level non-violent crimes like simple drug possession, from a felony to a misdemeanor, freeing up an estimated $1B per annum to be dedicated to useful things like crime prevention, school funding, mental health treatment, and victim services. Regulatory reforms like this are opening up sizable markets for both private and public sector participants.
GWPH: 81.63 (+0.09)
Novus MedPlan Passes Major Milestone With First Ever Medical Marijuana Cost Savings Plan
Marketwired - Wed Oct 15, 8:04AM CDT
Novus Acquisition & Development Corp (PINKSHEETS: NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of the health and wellness savings plan, "Novus MedPlan," is proud to announce that "Enrollment" has officially begun for patients looking to join the Novus MedPlan network.
Cannabis Industry Gears Up for Make-or-Break Moment in November
ACCESSWIRE - Tue Oct 14, 9:14AM CDT
Whitefish, MT / October 14, 2014 / Cannabis industry stocks moved lower last week, according to data from the Marijuana Index(TM), continuing its bearish 3-month trend alongside a broader decline affecting the U.S. stock market as a whole. Top gainers included MyECheck Inc. (OTC: MYEC), which jumped nearly 10% last week and 13% on Monday's session, after announcing a patent infringement lawsuit.
Novus Engages Hayden IR to Develop Comprehensive Investor Relations Program
ACCESSWIRE - Wed Aug 03, 7:30AM CDT
Proactive Outreach to Focus on Increasing Awareness and Enhancing Shareholder Value
Novus MedPlan Grows Its MMJ and Alternative Medicine Footprint
ACCESSWIRE - Mon Jun 08, 7:00AM CDT
WHITEFISH, MT / ACCESSWIRE / June 8, 2015 / Novus Acquisition & Development Corp. (OTC: NDEV), developer of a cost-saving healthcare program called "Novus MedPlan" for patients within the medical marijuana (MMJ) and wellness industries, has made substantial progress over the past few months growing its provider network, launching its online platform, and garnering the media attention needed to help it reach scale.
GWPH: 81.63 (+0.09), UAM: 6.84 (-0.11), MGLN: 56.18 (-1.06)
Nations First MMJ Medical Plan Portal Goes Live
ACCESSWIRE - Tue Mar 31, 8:30AM CDT
WHITEFISH, MT / ACCESSWIRE / March 31, 2015 / Novus Acquisition & Development Corp. (PINKSHEETS:NDEV) officially launched its Novus MedPlan in partnership with Proteus420 after months of anticipation from both patients and providers. With the alternative healthcare industry expected to surpass $12 billion in size, according to IBISWorld, the launch represents a key step forward in the complementary and alternative medicine ("CAM"
industry, which includes medical marijuana, alternative medicine, and holistic healing. GWPH: 81.63 (+0.09)
Novus MedPlan Progress Exceeds Expectations, Company Poised For Banner 2015
ACCESSWIRE - Tue Dec 30, 9:01AM CST
WHITEFISH, MT / ACCESSWIRE / December 30, 2014 / The rapid expansion of the cannabis industry has offered patients throughout the U.S. a ray of hope when it comes to treating a variety of conditions that medical marijuana (MMJ) is increasingly understood to be effective for. However, exorbitant costs for MMJ patients, associated with registration fees and other price pressures put on producers and distributors, have made MMJ treatments inaccessible to a sizeable portion of the market. This is why Novus Acquisition & Development Corp. (OTC: NDEV), created their innovative Novus MedPlan program, which offers MMJ patients a considerable discount on medicinals, as well as holistic and alternative medicines, using an exclusive provider network cost-savings model to grant members direct and easy access to the nearest providers in their state.
JNJ: 119.04 (+0.47), INSY: 15.17 (+0.19), GWPH: 81.63 (+0.09)
Novus Becomes an Insurance Leader as MMJ Market Approaches Tipping Point
ACCESSWIRE - Mon Dec 08, 9:21AM CST
WHITEFISH, MT / ACCESSWIRE / December 8, 2014 / A unique company in the MMJ space today that is focused on the medical insurance side of the business is Novus Acquisition & Development (OTC: NDEV). Novus provides health insurance and insurance related solutions to the growing wellness and MMJ markets using an innovative cost-saving provider network model that is administered via their wholly-owned Novus Medical Group subsidiary's Novus MedPlan. The timely rollout of the Novus MedPlan in states where MMJ is legal, which gives patients access to considerable discounts on MMJ products for a modest subscriber fee of under $20 a month, was recently highlighted in Forbes as the number one pick, taking the top slot out of a list of the eight hottest publicly traded companies to draw the interest of investors in this rapidly emerging sector.
CARA: 5.52 (+0.02), INSY: 15.17 (+0.19), GWPH: 81.63 (+0.09)
Earth Science Tech's Pioneering CBD Work Spearheaded By Leading Cancer Treatment/Diagnostic Expert
ACCESSWIRE - Wed Nov 19, 3:07PM CST
WHITEFISH, MT / ACCESSWIRE / November 19, 2014 / A growing body of data from numerous studies over the past decade has gradually led to a more complete understanding of cannabinoid biology and pharmacology, including efficacy as an appetite stimulant, analgesic (pain reliever) and treatment for neurological disorders like epilepsy. Similar efficacy data regarding cannabinoids performing broad-spectrum anti-tumor functions and producing palliative effects on cancer symptoms, documented by the National Cancer Institute, has made cannabinoid science a hot property in the world of modern oncology medicine. Needless to say, the emerging market surrounding cannabinoids has been booming of late, with a variety of sector players seeing increased interest from investors, ranging from cannabis-based medicine developers like Cannabis Science (OTC: CBIS), to innovative medical cannabis-focused healthcare solution providers, like Novus Acquisition & Development (OTC: NDEV).
GWPH: 81.63 (+0.09)
Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 81.63 (+0.09)
Novus MedPlan Cost-Saving Provider Network Offers A Strong Value Proposition
ACCESSWIRE - Fri Nov 07, 8:01AM CST
WHITEFISH, MT / ACCESSWIRE / November 7, 2014 / Marijuana reform was a key ballot initiative in seven states (as well as 17 municipalities and D.C.) this week, with more drug policy reform questions (most aimed at reforming or out outright repealing marijuana laws) on the ballot than at any time in the history of the country. In California, Proposition 47 was passed, transforming the lowest-level non-violent crimes like simple drug possession, from a felony to a misdemeanor, freeing up an estimated $1B per annum to be dedicated to useful things like crime prevention, school funding, mental health treatment, and victim services. Regulatory reforms like this are opening up sizable markets for both private and public sector participants.
GWPH: 81.63 (+0.09)
Novus MedPlan Passes Major Milestone With First Ever Medical Marijuana Cost Savings Plan
Marketwired - Wed Oct 15, 8:04AM CDT
Novus Acquisition & Development Corp (PINKSHEETS: NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of the health and wellness savings plan, "Novus MedPlan," is proud to announce that "Enrollment" has officially begun for patients looking to join the Novus MedPlan network.
Cannabis Industry Gears Up for Make-or-Break Moment in November
ACCESSWIRE - Tue Oct 14, 9:14AM CDT
Whitefish, MT / October 14, 2014 / Cannabis industry stocks moved lower last week, according to data from the Marijuana Index(TM), continuing its bearish 3-month trend alongside a broader decline affecting the U.S. stock market as a whole. Top gainers included MyECheck Inc. (OTC: MYEC), which jumped nearly 10% last week and 13% on Monday's session, after announcing a patent infringement lawsuit.
